Skip to main content
AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
7.10
-0.04 (-0.56%)
Dec 3, 2024, 11:52 AM EST - Market open

AngioDynamics Revenue

AngioDynamics had revenue of $67.49M in the quarter ending August 31, 2024, a decrease of -14.22%. This brings the company's revenue in the last twelve months to $292.73M, down -12.85% year-over-year. In the fiscal year ending May 31, 2024, AngioDynamics had annual revenue of $303.91M, down -10.28%.

Revenue (ttm)
$292.73M
Revenue Growth
-12.85%
P/S Ratio
0.99
Revenue / Employee
$391,345
Employees
748
Market Cap
288.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2024303.91M-34.84M-10.28%
May 31, 2023338.75M22.53M7.13%
May 31, 2022316.22M25.21M8.66%
May 31, 2021291.01M26.85M10.17%
May 31, 2020264.16M-6.48M-2.39%
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro
May 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OraSure Technologies 224.26M
LifeMD 193.06M
Personalis 87.49M
Mersana Therapeutics 34.84M
Ocugen 4.70M
Precigen 3.96M
Revenue Rankings

ANGO News

More News